BIOS - BioScrip, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
2.8500
+0.0700 (+2.52%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close2.7800
Open2.7500
Bid2.8200 x 2900
Ask2.8700 x 1300
Day's Range2.7400 - 2.9100
52 Week Range1.5600 - 4.1400
Volume991,011
Avg. Volume991,641
Market Cap424.114M
Beta (3Y Monthly)0.27
PE Ratio (TTM)N/A
EPS (TTM)-0.5230
Earnings DateAug 5, 2019 - Aug 9, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.85
Trade prices are not sourced from all markets
  • Is BioScrip Inc. (BIOS) A Good Stock To Buy?
    Insider Monkey15 days ago

    Is BioScrip Inc. (BIOS) A Good Stock To Buy?

    The first quarter was a breeze as Powell pivoted, and China seemed eager to reach a deal with Trump. Both the S&P 500 and Russell 2000 delivered very strong gains as a result, with the Russell 2000, which is composed of smaller companies, outperforming the large-cap stocks slightly during the first quarter. Unfortunately sentiment shifted […]

  • BioScrip, Inc. (BIOS) Shares March Higher, Can It Continue?
    Zacks18 days ago

    BioScrip, Inc. (BIOS) Shares March Higher, Can It Continue?

    As of late, it has definitely been a great time to be an investor in BioScrip, Inc. (BIOS).

  • GlobeNewswire24 days ago

    BIOS, CRAY, ZAYO SHAREHOLDER LEGAL UPDATE: Halper Sadeh LLP Announces Shareholder Class Actions Against the Following Companies – BIOS, CRAY, ZAYO

    NEW YORK, June 26, 2019 -- Halper Sadeh LLP, a global investor rights law firm, announces the filing of shareholder class action lawsuits against BioScrip, Inc. (NASDAQ: BIOS),.

  • GlobeNewswire26 days ago

    LogistiCare Announces Leadership Transition

    The Providence Service Corporation (“Providence”) (PRSC) and its subsidiary, LogistiCare Solutions, LLC (“LogistiCare”), today announced that effective immediately R. Carter Pate will serve as Interim Chief Executive Officer of LogistiCare.  Mr. Pate will continue his duties as Providence’s Interim CEO and assumes the responsibilities of Jeff Felton, who has resigned as CEO of LogistiCare effective immediately. Mr. Pate will remain as Interim CEO of Providence and LogistiCare until December 31, 2019.  Over the next six months, Mr. Pate will work with Providence’s Board of Directors to conduct a search internally and externally to identify a permanent CEO for the combined business. Carter Pate is the Founder and Chief Executive Officer of Carter Pate, LLC, a consulting firm he founded in 2014.  Since 2017 he has served as the Interim CEO of Providence Service Corporation (PRSC).

  • PR Newswire28 days ago

    URGENT ALERT: Monteverde & Associates PC Launches an Investigation Regarding the Following Merger

    NEW YORK , June 21, 2019 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York ...

  • BioScrip, Inc.'s Shares March Higher, Can It Continue?
    Zackslast month

    BioScrip, Inc.'s Shares March Higher, Can It Continue?

    As of late, it has definitely been a great time to be an investor in BioScrip.

  • GlobeNewswirelast month

    Key Members of BioScrip’s Leadership Team to Continue in Executive Roles with Combined Company Following Close of Option Care Merger

    Dan Greenleaf, President and Chief Executive Officer of BioScrip, will become Special Advisor to the newly combined company’s Board Chairman, Harry Kraemer, and Chief Executive Officer, John Rademacher.   Mr. Greenleaf will provide strategic and operational counsel to ensure a smooth transition, optimize the integration of both companies, and drive long-term growth opportunities.

  • GlobeNewswirelast month

    RLH Corporation Announces Changes to Its Board of Directors

    Adds Accomplished Independent Director R. Carter Pate to Board and Audit Committee Announces Retirement of Director, James P. Evans, Chair of the Board’s Nominating and.

  • BioScrip (BIOS) Up 5.2% Since Last Earnings Report: Can It Continue?
    Zacks2 months ago

    BioScrip (BIOS) Up 5.2% Since Last Earnings Report: Can It Continue?

    BioScrip (BIOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • GlobeNewswire2 months ago

    BioScrip to Participate in Upcoming Investor Conferences

    Given BioScrip’s pending combination with Option Care, Option Care’s Chief Executive Officer, John Rademacher, and Chief Financial Officer, Mike Shapiro, plan to accompany BioScrip’s senior leadership at these events.  A live webcast of the Jefferies group presentation and copies of the materials presented can be accessed via BioScrip’s Investor Relations website at https://investors.bioscrip.com/ or through the following link: http://wsw.com/webcast/jeff118/bios/.

  • Moody's2 months ago

    BioScrip, Inc. -- Moody's upgrades BioScrip, Inc.'s Corporate Family Rating to B3, outlook stable

    Moody's Investors Service ("Moody's") today upgraded the Corporate Family Rating (CFR) of BioScrip, Inc. ("BioScrip") to B3 from Caa1 and upgraded the Probability of Default to B3-PD from Caa1-PD. At the same time, Moody's upgraded the Speculative Grade Liquidity Rating to SGL-3 from SGL-4 and assigned a B2 (LGD 3) rating to the proposed $925 million First Lien Term Loan B. The outlook is stable. The upgrade reflects the improvement in BioScrip's credit profile due to the pending merger with HC Group Holdings III, Inc. (dba Option Care).

  • Here’s What Hedge Funds Think About BioScrip Inc. (BIOS)
    Insider Monkey2 months ago

    Here’s What Hedge Funds Think About BioScrip Inc. (BIOS)

    The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the fourth quarter, which unveil their equity positions as of December 31. We went through these filings, fixed typos and other more significant errors and identified the changes in hedge fund positions. Our extensive review […]

  • BioScrip's Option Care Merger on Track, Q1 Loss Narrows
    Zacks2 months ago

    BioScrip's Option Care Merger on Track, Q1 Loss Narrows

    BioScrip (BIOS) is highly upbeat about the strategic and financial virtues of Option Care consolidation.

  • GlobeNewswire3 months ago

    MERGER INVESTIGATION NOTICE: Kaskela Law LLC Announces Shareholder Investigation of BioScrip, Inc. – BIOS

    NEWTOWN SQUARE, Pa., May 03, 2019 -- Kaskela Law LLC announces that it is investigating BioScrip, Inc. (“BioScrip” or the “Company”) (Nasdaq: BIOS) on behalf of the Company’s.

  • BioScrip (BIOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
    Zacks3 months ago

    BioScrip (BIOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

    BioScrip (BIOS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • BioScrip (BIOS) Reports Q1 Loss, Tops Revenue Estimates
    Zacks3 months ago

    BioScrip (BIOS) Reports Q1 Loss, Tops Revenue Estimates

    BioScrip (BIOS) delivered earnings and revenue surprises of 16.67% and 0.82%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press3 months ago

    BioScrip: 1Q Earnings Snapshot

    On a per-share basis, the Denver-based company said it had a loss of 10 cents. The infusion and home care services company posted revenue of $179 million in the period. The company's shares closed at $1.90. ...

  • GlobeNewswire3 months ago

    BioScrip Reports First Quarter 2019 Financial Results

    DENVER, May 02, 2019 -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions,.

  • GlobeNewswire3 months ago

    BioScrip, Inc. Provides Merger Update

    BioScrip, Inc. (BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today provided an update on its proposed merger with Option Care Enterprises, Inc. (“Option Care”). The Company expects to file the preliminary Option Care merger proxy statement the week of April 29, 2019 with the U.S. Securities and Exchange Commission (“SEC”).  After the proxy statement is filed, management from both BioScrip and Option Care plan to conduct joint analyst and investor meetings.  As part of the analyst and investor meetings, the Company will file an investor presentation with the SEC that will include a business and merger update.

  • Moody's3 months ago

    HC Group Holdings III, Inc. -- Moody's announces completion of a periodic review of ratings of HC Group Holdings III, Inc.

    Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of HC Group Holdings III, Inc. New York, April 18, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of HC Group Holdings III, Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

  • Moving Average Crossover Alert: BioScrip
    Zacks3 months ago

    Moving Average Crossover Alert: BioScrip

    BioScrip, Inc. (BIOS) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.

  • Why Is BioScrip (BIOS) Down 50.4% Since Last Earnings Report?
    Zacks3 months ago

    Why Is BioScrip (BIOS) Down 50.4% Since Last Earnings Report?

    BioScrip (BIOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • New Strong Sell Stocks for April 11th
    Zacks3 months ago

    New Strong Sell Stocks for April 11th

    Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today.

  • New Strong Sell Stocks for April 9th
    Zacks3 months ago

    New Strong Sell Stocks for April 9th

    Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today.

  • Thomson Reuters StreetEvents4 months ago

    Edited Transcript of BIOS earnings conference call or presentation 15-Mar-19 1:00pm GMT

    Q4 2018 BioScrip Inc Earnings and Definitive Merger Agreement with Option Care Call